News

FDA approves GSK’s prefilled syringe presentation of Shingrix
Administering Shingrix previously required combining a lyophilised antigen with a liquid adjuvant from two separate vials.
pharmaphorum1h
GSK's growth plans dented by Blenrep setback
The panel expressed concerns about the proposed doses of Blenrep (belantamab mafodotin) in GSK's marketing application, ...
GSK slides Tuesday, underperforms market
GSK PLC closed 16.45% short of its 52-week high of £16.79, which the company reached on September 9th.
Fierce Biotech2d
GSK telegraphs 'very limited number' of job cuts amid R&D investment spree
With GSK kicking its research and development engine into high gear in recent years, a shuffling of the scientific priorities ...
FDA votes against overall benefit/risk profile of GSK's multiple myeloma candidate at proposed dosage
Drugmaker GSK said on Friday that the US Food and Drug Administration's Oncologic Drugs Advisory Committee had voted against ...
Fierce Pharma15h
FDA advisors spurn GSK’s Blenrep comeback dreams on safety, trial concerns
On a quest to bring its multiple myeloma antibody-drug conjugate (ADC) Blenrep back to the U.S. | Members of the FDA's Oncologic Drugs Advisory Committee voiced concerns with ocular toxicity side ...
Explore more
GSK's Linerixibat Poised To Address Substantial Unmet Need For The Treatment Of Pruritus Associated With Primary Biliary Cholangitis, According To Spherix Global Insights
Despite new market entrants in the form of Gilead's Livdelzi and Ipsen's Iqirvo, US gastroenterologists report nearly half of PBC patients suffer fro ...
GSK wins FDA nod for new shingles vaccine format
GSK (GSK) stock in focus as the U.S. FDA approves a new prefilled syringe presentation of its shingles vaccine, Shingrix.